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Background Preoperative cardiovascular (CV) risk stratification in liver transplant (LvTx) candidates has proven challenging due to limitations of 
current noninvasive modalities. Additionally, the evaluation can be cumbersome and expensive given the need for separate cardiac, vascular and 
abdominal imaging. Over the last decade cardiovascular MRI (CMR) has emerged as the ‘gold standard’ for many important CV metrics used to 
define such risk due to its unparalleled spatial resolution, lack of ionizing radiation and intrinsic 3D capabilities.
Hypothesis We hypothesize that it is feasible to perform a CMR driven preoperative cardio-hepatic evaluation in LvTx candidates as a ‘one-stop 
shop’ in a dedicated CMR suite.
Methods In this pilot study, pts underwent LV/RV function assessment (SSFP), stress CMR, and thoracoabdominal MRI/MRA. Pharmacologic stress 
CMR was done with regadenoson, adenosine, or dobutamine. Viability was assessed by LGE. Cardiologists managed pts during acquisition and 
interpreted CMR studies. Diagnostic radiologists only interpreted abdominal MRI/A.
Results Over 2 years, 51 LvTx candidates (56±7 years, 35% female; mean MELD score of 15, Child-Pugh Class ≥ B) underwent CMR with an average 
imaging time of 72±23 minutes. This included 7 pts on mechanical ventilation and 6 on vasopressors for shock. All pts completed SSFP CMR, 
98% completed stress CMR, 82% completed DHE viability (3 renal failure pts underwent dobutamine CMR), 94% completed liver MRI, and 88% 
completed MRA. Four pts had coronary angiography (3 for ischemia on CMR and 1 for post-operative ischemia), and none had flow-limiting coronary 
disease. Nine pts underwent orthotopic LvTx (mean 74 days to LvTx after MRI). There were 7 ascertained deaths in the non-LvTx group (mean 23 
days post CMR) and 1 death in the LvTx group (116 days after MRI, 11 days after LvTx). Average cost saving was >$1800/per pt and the saving of at 
least 2 days of additional testing per pt.
Conclusion It is feasible and efficient to perform comprehensive preoperative liver transplant imaging in a CMR suite, even in critically ill patients. 
Future evaluations will systematically focus on prognostic accuracy, patient convenience, and cost effectiveness.
